National Bank of Canada
NAUT icon

National Bank of Canada’s Nautilus Biotechnolgy NAUT Stock Holding History

National Bank of Canada’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16K Buy
+300
New +$737 ﹤0.01% 2664

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

National Bank of Canada's NAUT Position: Q1 2026 in Review

National Bank of Canada opened a new position in Nautilus Biotechnolgy (NAUT) in Q1 2026: 300 shares worth $1.16K. The stake represents ﹤0.01% of the portfolio and ranks #2664 among its holdings.

81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • National Bank of Canada held 300 shares of Nautilus Biotechnolgy worth $1.16K as of Q1 2026.
  • Nautilus Biotechnolgy was a new National Bank of Canada position in Q1 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2664 holding.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.